Peroxisome proliferator-activated receptor γ1 (PPARγ1) expresses in rat mesangial cells and PPARγ agonists modulate its differentiation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1497, Issue 1, 2000, Pages 148-154

  Asano, Tamotsu ^a   Wakisaka, Masanori ^a   Yoshinari, Mototaka ^a   Iino, Kenzo ^a   Sonoki, Kazuo ^a   Iwase, Masanori ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cell differentiation; Peroxisome proliferator activated receptor ; Rat mesangial cell; Troglitazone

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETIC NEPHROPATHY; IMMUNOBLOTTING; KIDNEY INTERSTITIUM; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLOMERULAR MESANGIUM; NUCLEAR PROTEINS; OLIGONUCLEOTIDES; PROSTAGLANDIN D2; PROTEIN BINDING; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 0034595727     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(00)00054-9     Document Type: Article

References (26)

1. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferations. Nature. 347:1990;645-650.
2. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA. 90:1993;2160-2164.
3. Keller H., Mahfoudi A., Dreyer C., Hihi A.K., Medin J., Ozato K., Wahli W. Peroxisome proliferator-activated receptors and lipid metabolism. Ann. New York Acad. Sci. 684:1993;157-173.
4. Chawla A., Schwarz E.J., Dimaculangan D.D., Lazar M.A. Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology. 135:1994;798-800.
5. Iijima K., Yoshizumi M., Ako J., Eto M., Kim S., Hashimoto M., Sugimoto N., Liang Y.Q., Sudoh N., Toba K., Ouchi Y. Expression of peroxisome proliferator-activated receptor gamma (PPARγ) in rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 247:1998;353-356.
6. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
7. Marx N., Sukhova G., Murphy C., Libby P., Plutzky J. Macrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153:1998;17-23.
8. Law R.E., Meehan W.P., Xi X.P., Graf K., Wuthrich D.A., Coats W., Faxon D., Hsueh W.A. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98:1996;1897-1905.
9. Morikang E., Benson S.C., Kurtz T.W., Pershadsingh H.A. Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes. Am. J. Hypertens. 10:1997;440-446.
10. T. Asano, M. Wakisaka, M. Yoshinari, S. Nakamura, Y. Doi, M. Fujishima, Troglitazone enhances glycolysis and improves intracellular glucose metabolism in rat mesangial cells, Metabolism, in press.
11. Johnson R.J., Iida H., Alpers C.E., Majesky M.W., Schwartz S.M., Pritzi P., Gordon K., Gown A.M. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J. Clin. Invest. 87:1991;847-858.
12. Makino H., Kashihara N., Sugiyama H., Kanao K., Sekikawa T., Okamoto K., Maeshima Y., Ota Z., Nagai R. Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes. 45:1995;488-495.
13. Masugi J., Tamori Y., Kasuga M. Inhibition of adipogenesis by a COOH-terminary truncated mutant of PPARγ2 in 3T3-L1 cells. Biochem. Biophys. Res. Commun. 264:1999;93-99.
14. Auwerx J. PPARγ the ultimate thrifty gene. Diabetologia. 42:1999;1033-1049.
15. Fajas L., Auboef D., Raspe E., Schoonjans K., Lefebvre A.-M., Saladin R., Najib J., Laville M., Fruchart J.-C., Deeb S., Vidal-Puig A., Flier J., Briggs M.R., Steals B., Vidal H., Auwerx J. The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem. 272:1997;18779-18789.
16. Johnson R.J., Floege J., Yoshimura A., Iida H., Couser W.G., Alpers C.E. The activated mesangial cell: a glomerular 'myofibroblast'? J. Am. Soc. Nephrol. 2:1992;S190-197.
17. Kitamura M., Mitarai T., Nagasawa R., Maruyama N. Differentiated phenotype of glomerular mesangial cells in nodular culture. Am. J. Physiol. 270:1996;F614-622.
18. Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., Saperstein R., Smith R.G., Leibowitz M.D. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology. 137:1996;354-366.
19. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation (PPARγ). Cell. 83:1995;813-819.
20. Hattori Y., Hattori S., Kasai K. Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells. Hypertension. 33:1999;943-948.
21. 12,14-prostaglandin J2. Proc. Natl. Acad. Sci. USA. 96:1999;4668-4673.
22. Braissant O., Desvergne B. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β and -γ in the adult rat. Endocrinology. 137:1995;354-366.
23. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., Delerive P., Fade A., Chinetti G., Fruchart J.C., Najib J., Maclouf J., Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature. 393:1998;790-793.
24. Wakisaka M., Spiro M.J., Spiro R.G. Synthesis of type IV collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. Diabetes. 43:1994;95-103.
25. Fujii M., Takemura R., Yamaguchi M., Hasegawa G., Shigeta H., Nakano K., Kondo M. Troglitazone (CS-045) ameliorates albuminuria in streptozotocin-induced diabetic rats. Metabolism. 46:1997;981-983.
26. Imano E., Kanda T., Nakatani Y., Nishida T., Arai K., Motomura M., Kajimoto Y., Yamasaki Y., Hori M. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Diabetes Care. 21:1998;2135-2139.